Stay updated on TERN-201 Safety and Efficacy in NASH Clinical Trial
Sign up to get notified when there's something new on the TERN-201 Safety and Efficacy in NASH Clinical Trial page.

Latest updates to the TERN-201 Safety and Efficacy in NASH Clinical Trial page
- CheckyesterdayChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check16 days agoChange DetectedRemoved the keywords/MeSH topics 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics' from the page.SummaryDifference0.2%

- Check23 days agoChange DetectedAdded related topics entries for Non-alcoholic fatty liver disease, including MedlinePlus Genetics. This improves access to NAFLD-related resources.SummaryDifference0.2%

- Check30 days agoChange DetectedThe page now displays Revision: v3.5.0. Related topics such as Non-alcoholic fatty liver disease and MedlinePlus Genetics, and the older Revision: v3.4.3, have been removed.SummaryDifference0.2%

- Check37 days agoChange DetectedThe page revision label changed from v3.4.2 to v3.4.3.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded related topic entries: 'Non-alcoholic fatty liver disease' and 'MedlinePlus Genetics'. These appear in the page's related topics/MeSH terms section.SummaryDifference0.2%

Stay in the know with updates to TERN-201 Safety and Efficacy in NASH Clinical Trial
Enter your email address, and we'll notify you when there's something new on the TERN-201 Safety and Efficacy in NASH Clinical Trial page.